Year To Quarter End Statement Of Income

Delta-Fly Pharma, Inc. - Filing #7246013

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Year to quarter end statement of income
Statement of income
Selling, general and administrative expenses
Remuneration for directors (and other officers)
73,800,000 JPY
77,149,000 JPY
Taxes and dues
59,074,000 JPY
56,262,000 JPY
Operating profit (loss)
-1,708,224,000 JPY
-1,403,464,000 JPY
Non-operating income
Interest income
337,000 JPY
14,000 JPY
Non-operating income
348,000 JPY
16,000 JPY
Non-operating expenses
Non-operating expenses
10,787,000 JPY
23,443,000 JPY
Ordinary profit (loss)
-1,718,662,000 JPY
-1,426,891,000 JPY
Profit (loss) before income taxes
-1,718,662,000 JPY
-1,426,891,000 JPY
Income taxes - current
2,502,000 JPY
2,502,000 JPY
Income taxes
2,502,000 JPY
2,502,000 JPY
Profit (loss)
-1,721,164,000 JPY
-1,721,164,000 JPY
-1,721,164,000 JPY
-1,721,164,000 JPY
-1,429,393,000 JPY
-1,429,393,000 JPY
-1,429,393,000 JPY
-1,429,393,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.